Phase transition of WTAP regulates m6A modification of interferon-stimulated genes
eLife · 2025
DOI: 10.7554/elife.100601 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Sihui Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, C…. Hauptthemen laut MEDLINE: Adenosine, Interferon-beta, Gene Expression Regulation, Cell Cycle Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
N 6 -methyladenosine (m 6 A) is the most prevalent modification of mRNA which controls diverse physiological processes. Although m 6 A modification has been reported to regulate type I interferon (IFN) responses by targeting the mRNA of IFN-β and the interferon-stimulated genes (ISGs), the detailed mechanism of how m 6 A methyltransferase complex (MTC) rapidly responds to conduct the modification on nascent mRNA during IFN-β stimulation remains largely unclear. Here, we demonstrate that WTAP, the adaptor protein of m 6 A MTC, undergoes dephosphorylation-regulated phase transition from aggregates to liquid-like condensates under IFN-β stimulation, thereby mediating m 6 A modification of a subset of ISGs to restrict their expression. The phase transition of WTAP promotes the interaction with nucleus-translocated transcription factor STAT1, recruits MTC to the promoter regions of ISGs and directs the co-transcriptional m 6 A modification on ISG mRNAs. Collectively, our findings reveal a novel regulatory role of WTAP phase transition in manipulating signaling pathways and fine-tuning immune response by orchestrating dynamic m 6 A modification through the cooperation of transcription factors and MTC. Our findings unveil a novel mechanism by which WTAP phase transition controls immune homeostasis via transcription factor-MTC-driven dynamic m 6 A modification, thereby proposing a potential therapeutic target for alleviating immune dysregulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
- Beijing Frontier Research Center for Biological Structure, Tsinghua University, Beijing, China.
- Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China.
- Innovation Center of the Sixth Affiliated Hospital, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
- Guangdong Institute of Gastroenterology, Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Sihui Cai, Jie Zhou, Xiaotong Luo, Shouheng Jin, Jun Cui
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Cai, S., Zhou, J., Luo, X., Zhang, C., Jin, S., Ren, J., & Cui, J. (2025). Phase transition of WTAP regulates m6A modification of interferon-stimulated genes. eLife. https://doi.org/10.7554/elife.100601
Vancouver
Cai S, Zhou J, Luo X, Zhang C, Jin S, Ren J, et al. Phase transition of WTAP regulates m6A modification of interferon-stimulated genes. eLife. 2025. doi:10.7554/elife.100601
BibTeX
@article{Cai2025,
author = {Cai, Sihui and Zhou, Jie and Luo, Xiaotong and Zhang, Chenqiu and Jin, Shouheng and Ren, Jian and Cui, Jun},
title = {Phase transition of WTAP regulates m6A modification of interferon-stimulated genes},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.100601}
}
EUVIMED